Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 247-499-3 | CAS number: 26172-54-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
It was concluded that MIT.HCl did not induce mutation in five histidine-requiring strains (TA98, TA100, TA1535, TA1537 and TA102) of Salmonella typhimurium when tested under the conditions of this study. These conditions included treatments at concentrations limited by toxicity in the absence and in the presence of a rat liver metabolic activation system (S9), utilizing the plate incorporation methodology (absence and presence of S9) or pre-incubation methodology (presence of S9).
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 25 July 2017 to 1 October 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 1997
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- - Identification: MIT.HCl (Methyl isothiazolinone hydrochloric acid)
- CAS no.: 26172-54-3
- Source and lot/batch No.of test material: Sigma-Aldrich / 10013913
- Expiration date of the lot/batch: 30 Nov 2018
- Purity test date: 23 Nov 2016
- Purity: >99.9%
- Apperance: White to light beige powder
- Moelcular weight: 151.61 g/mol
- Storage condition of test material: 2 to 8°C, protected from light - Target gene:
- see below
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- β-Naphthoflavone/Phenobarbital
- Test concentrations with justification for top dose:
- Experimental 1 (plate incorporation): +/- S9: All strains: 0, 5, 16, 50, 160, 500, 1600, 5000 ug/plate
Experiment 2 (plate incorporation): - S9: All strains: 0, 9.375, 18.75, 37.5, 75, 150, 300, 600 ug/plate
Experimental 2 (plate incorporation): + S9: TA98, TA1535, TA102: 0, 18.75, 37.5, 150, 300, 600, 1200 ug/plate
Experimental 2 (plate incorporation): + S9: TA100, TA1537, TA102: 0,9.375, 18.75, 37.5, 150, 300, 600 ug/plate - Vehicle / solvent:
- DMSO
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- dimethyl sulphoxide (DMSO)
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 2-nitrofluorene
- Remarks:
- -S9: TA98
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- Remarks:
- -S9: TA100, TA1535
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- Remarks:
- -S9: TA1537
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- mitomycin C
- Remarks:
- -S9: TA102
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- benzo(a)pyrene
- Remarks:
- +S9: TA98
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 2-aminoanthracene
- Remarks:
- +S9: TA100, TA1535, TA1537 TA102
- Details on test system and experimental conditions:
- The plate incorporation methodology was used for Experiment 1 (-/+ S9) and Experiemtn 2 (-S9). In addition the pre-incubation methodology was in Experiment 2 (+S9). Triplicate plates were used for the main tests.
- Evaluation criteria:
- A concentration related increase in revertant numbers was =>1.5-fold (in strain TA102), =>2-fold (in strains TA98 or TA100) or =>3-fold (in strains TA1535 or TA1537) the concurrent vehicle control values.
The test article was considered positive in this assay if the above criterion was met.
The test article was considered negative in this assay if the above criterion was not met - Statistics:
- Statistics not warranted
- Key result
- Species / strain:
- other: S. typhimurium TA1535, TA1537, TA98, TA100, TA102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Conclusions:
- It was concluded that MIT.HCl did not induce mutation in five histidine-requiring strains (TA98, TA100, TA1535, TA1537 and TA102) of Salmonella typhimurium when tested under the conditions of this study. These conditions included treatments at concentrations limited by toxicity in the absence and in the presence of a rat liver metabolic activation system (S9), utilizing the plate incorporation methodology (absence and presence of S9) or pre-incubation methodology (presence of S9).
- Executive summary:
MIT.HCl was assayed for mutation in five histidine-requiring strains (TA98, TA100, TA1535,TA1537 and TA102) of Salmonella typhimurium, both in the absence and in the presence of metabolic activation by β -naphthoflavone / Phenobarbital induced rat liver post-mitochondrial fraction (S9), in two independent experiments.
All MIT.HCl treatments in this study were performed using formulations prepared in anhydrous analytical grade dimethyl sulphoxide (DMSO).
In Mutation Experiment 1, treatments of all tester strains were performed in the absence and in the presence of S9, using final concentrations of MIT.HCl at 5, 16, 50, 160, 500, 1600 and 5000 µg/plate, plus vehicle and positive controls. Following these treatments, evidence of toxicity was observed at 500, 1600 and 5000 µg/plate in all strains in the absence and presence of S9.
In Mutation Experiment 2, treatments of all the tester strains were performed in the absence and in the presence of S9. The maximum test concentration was reduced based on strain specific toxicity observed in Mutation Experiment 1 and narrowed concentration intervals were employed in order to examine more closely those concentrations of MIT.HCl approaching the maximum test concentration and considered therefore most likely to provide evidence of any mutagenic activity. The concentration ranges used in Mutation Experiment 2 were as follows:
· 9.375, 18.75, 37.5, 75, 150, 300 and 600 µg/plate for all strains in the absence of S9
· 9.375, 18.75, 37.5, 75, 150, 300 and 600 µg/plate for strains TA100 and TA1537 in the presence of S9
· 18.75, 37.5, 75, 150, 300, 600 and 1200 µg/plate for strains TA98, TA1535 and TA102 in the presence of S9
·
In addition, all treatments in the presence of S-9 were further modified by the inclusion of a pre-incubation step. In this way, it was hoped to increase the range of mutagenic chemicals that could be detected using this assay system.
Following treatments in the absence of S9, evidence of toxicity in the form of a complete killing of the test bacteria, was observed at 600 µg/plate in all strains. A slight thinning of the background bacterial lawn was also noted in all strains except TA1537, at 300 µg/plate and at 150 µg/plate in strain TA100.
Following treatments in the presence of S9, evidence of toxicity ranging from a slight thinning of the background bacterial lawn to a complete killing of the test bacteria, was observed at 150 µg/plate and above in strain TA1537, at 300 µg/plate and above in strains TA98, TA100 and TA1535 and at 600 µg/plate and above in strain TA102.
The test article was completely soluble in the assay system at all concentrations treated.
Vehicle and positive control treatments were included for all strains. The mean numbers of revertant colonies counts fell within acceptable ranges for vehicle control treatments and were elevated by positive control treatments.
Following MIT.HCl treatments of all the test strains in the absence and presence of S9, no biologically relevant increases in revertant numbers were observed. This study was considered therefore to have provided no evidence of anyMIT.HClmutagenic activity in this assay system.
It was concluded that MIT.HCl did not induce mutation in five histidine-requiring strains (TA98, TA100, TA1535, TA1537 and TA102) of Salmonella typhimurium when tested under the conditions of this study. These conditions included treatments at concentrations limited by toxicity in the absence and in the presence of a rat liver metabolic activation system (S9), utilizing the plate incorporation methodology (absence and presence of S9) or pre-incubation methodology (presence of S9).
Reference
A. Mutation experiment 1:
Mutation Experiment 1 treatments of all tester strains were performed utilizing the plate incorporation methodology in the absence and in the presence of S‑9, using final concentrations ofMIT.HClat 5, 16, 50, 160, 500, 1600 and 5000 µg/plate, plus vehicle and positive controls. Following these treatments, evidence of toxicity ranging from a slight thinning of the background bacterial lawn with a marked reduction in revertant numbers to a complete killing of the test bacteria, was observed at 500, 1600 and 5000 µg/plate in all strains in the absence and presence of S-9.
Table 7.6.1/01-1: Bacterial (reverse) gene mutation – Main mutation experiment 1
Conc. (ug/plate) |
TA98 |
TA100 |
TA1535 |
TA1537 |
TA102 |
||||||
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
||
0 |
28.7 |
36.0 |
111.0 |
109.3 |
8.3 |
20.7 |
7.0 |
8.0 |
259.3 |
258.7 |
|
5 |
23.7 |
35.3 |
93.3 |
111.7 |
15.0 |
15.0 |
10.0 |
10.7 |
258.7 |
270.3 |
|
16 |
27.0 |
34.0 |
100.3 |
105.3 |
14.3 |
14.7 |
10.7 |
11.5 |
298.0 |
265.7 |
|
50 |
30.0 |
36.3 |
111.0 |
113.0 |
15.0 |
17.0 |
10.3 |
8.7 |
261.7 |
271.7 |
|
160 |
27.3 |
33.7 |
91.7 |
96.7 |
13.7 |
9.7 |
10.7 |
8.3 |
246.0 |
250.0 |
|
500 |
T |
16.7S |
T |
T |
T |
4.7V |
T |
T |
T |
37.0V |
|
1600 |
T |
T |
T |
T |
T |
T |
T |
T |
T |
T |
|
5000 |
T |
T |
T |
T |
T |
T |
T |
T |
T |
T |
|
+ve |
561.7 |
193.3 |
553.0 |
946.7 |
501.0 |
137.0 |
84.3 |
147.3 |
610.0 |
1150.7 |
|
S: Slight thinning of background bacterial lawn T: Toxic, no revertant colonies V: Very thin background bacterial lawn -S9 (absence of metabolic activation) TA98: 2-nitrofluorene TA100, TA1535: Na azide TA1537: 9-aminoacridine TA102: mitomycin C |
+S9 (presence of metabolic activation) TA98: Benzo[a]pyrene TA100, TA1535, TA1537, TA102: 2-aminoanthracene |
||||||||||
B.Mutation experiment 2:
Mutation Experiment 2 treatments of all the tester strains were performed in the absence (utilising the plate incorporation methodology) and in the presence of S-9. The maximum test concentration was reduced based on strain specific toxicity observed in Mutation Experiment 1 and narrowed concentration intervals were employed in order to examine more closely those concentrations of MIT.HCl approaching the maximum test concentration and considered therefore most likely to provide evidence of any mutagenic activity. The concentration ranges used in Mutation Experiment 2 were as follows:
· 9.375, 18.75, 37.5, 75, 150, 300 and 600 µg/plate for all strains in the absence of S-9
· 9.375, 18.75, 37.5, 75, 150, 300 and 600 µg/plate for strains TA100 and TA1537 in the presence of S-9
· 18.75, 37.5, 75, 150, 300, 600 and 1200 µg/plate for strains TA98, TA1535 and TA102 in the presence of S-9.
In addition, all treatments in the presence of S-9 were further modified by the inclusion of a pre-incubation step. In this way, it was hoped to increase the range of mutagenic chemicals that could be detected using this assay system.
Following treatments in the absence of S-9, evidence of toxicity in the form of a complete killing of the test bacteria, was observed at 600 µg/plate in all strains. A slight thinning of the background bacterial lawn was also noted in all strains except TA1537 at 300 µg/plate and at 150 µg/plate in strain TA100.
Following treatments in the presence of S-9, evidence of toxicity ranging from a slight thinning of the background bacterial lawn to a complete killing of the test bacteria, was observed at 150 µg/plate and above in strain TA1537, at 300 µg/plate and above in strains TA98, TA100 and TA1535 and at 600 µg/plate and above in strain TA102.
Table 7.6.1/01-2: Bacterial (reverse) gene mutation – Main mutation experiment 2
Conc. (ug/plate) |
TA98 |
TA100 |
TA1535 |
TA1537 |
TA102 |
||||||
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
||
0 |
25.7 |
39.7 |
121.3 |
149.3 |
27.0 |
23.3 |
7.7 |
10.7 |
309.0 |
367.7 |
|
9.375 |
22.0 |
- |
113.3 |
125.7 |
18.0 |
- |
9.0 |
15.0 |
319.0 |
- |
|
18.75 |
16.7 |
39.7 |
127.7 |
139.0 |
17.0 |
28.3 |
11.0 |
16.7 |
328.7 |
331.0 |
|
37.5 |
19.3 |
28.0 |
120.3 |
144.3 |
18.3 |
23.7 |
9.0 |
12.7 |
314.0 |
348.3 |
|
75 |
19.7 |
42.7 |
127.7 |
132.3 |
14.7 |
19.7 |
8.7 |
13.3 |
298.7 |
338.7 |
|
150 |
21.0 |
39.0 |
130.3S |
148.0 |
13.0 |
20.0 |
10.7 |
11.0S |
297.0 |
277.7 |
|
300 |
14.7S |
32.7S |
174.0S |
217.3S |
8.7S |
13.3S |
9.7 |
T |
201.0S |
261.3 |
|
600 |
T |
T |
T |
T |
T |
T |
T |
T |
T |
T |
|
1200 |
- |
T |
- |
- |
- |
T |
- |
- |
- |
T |
|
+ve |
462.7 |
270.0 |
534.3 |
1167.7 |
523.7 |
135.0 |
287.7 |
103.0 |
773.7 |
2132.7 |
|
S: Slight thinning of background bacterial lawn T: Toxic, no revertant colonies -S9 (absence of metabolic activation) TA98: 2-nitrofluorene TA100, TA1535: Na azide TA1537: 9-aminoacridine TA102: mitomycin C |
+S9 (presence of metabolic activation) TA98: Benzo[a]pyrene TA100, TA1535, TA1537, TA102: 2-aminoanthracene |
||||||||||
The positive controls induced an acceptable increase in revertant colony numbers, thereby demonstrating the sensitivity and specificity of the test system.
Following MIT.HCltreatments of all the test strains in the absence and presence of S-9, no increases in revertant numbers were observed =>1.5-fold (in strain TA102), =>2-fold (in strains TA98or TA100) or =>3-fold (strains TA1535 or TA1537) the concurrent vehicle control. This study was considered therefore to have provided no evidence of any MIT.HCl mutagenic activity in this assay system
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Mode of Action Analysis / Human Relevance Framework
n/a
Additional information
n/a
Justification for classification or non-classification
Comparison with the CLP criteria
There was no indication that MIT.HCl has a mutagenic effect in the in vitro bacterial (reverse) gene mutation assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.